BBC Among Health Care ETFs
End-of-day Nov 18, 2026 · 32 Health care ETFs by 1Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.0% | −12.0% | −6.7% | −26.2% | +3.1% | +23.0% | +135.6% | −9.6% | +127.0% | +56.0% |
| Peer average | −0.9% | −5.3% | −1.4% | −2.4% | +17.0% | +21.8% | +68.8% | +23.4% | +169.9% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$24 of every $1,000 in BBC is Kodiak
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | KODKodiak Sciences | Healthcare | 2.35% | $235.46 | 7,839 | $759K |
| 2 | XNCRXencor | Healthcare | 2.32% | $231.80 | 22K | $747K |
| 3 | TRAXFirst Tracks Biotherapeutics | Healthcare | 2.05% | $204.62 | 15K | $659K |
| 4 | SLSSELLAS Life Sciences Group | Healthcare | 2.03% | $202.62 | 34K | $653K |
| 5 | REPLReplimune Group | Healthcare | 1.84% | $183.69 | 30K | $592K |
| 6 | ABCLAbCellera Biologics | Healthcare | 1.74% | $174.37 | 51K | $562K |
| 7 | AMLXAmylyx Pharmaceuticals | Healthcare | 1.56% | $156.26 | 18K | $504K |
| 8 | VRDNViridian Therapeutics | Healthcare | 1.52% | $152.31 | 16K | $491K |
| 9 | SGPSpyGlass Pharma | Healthcare | 1.41% | $141.22 | 14K | $455K |
| 10 | MBXMBX Biosciences | Healthcare | 1.24% | $123.89 | 7,519 | $399K |
| 11 | LBRXLB Pharmaceuticals | Healthcare | 1.17% | $117.47 | 9,394 | $379K |
| 12 | KYMRKymera Therapeutics | Healthcare | 1.17% | $116.78 | 3,097 | $376K |
| 13 | ZBIOZenas Biopharma | Healthcare | 1.16% | $116.08 | 13K | $374K |
| 14 | PRMEPrime Medicine | Healthcare | 1.15% | $114.63 | 96K | $369K |
| 15 | ORKAOruka Therapeutics | Healthcare | 1.14% | $114.17 | 3,820 | $368K |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | KOD | Kodiak Sciences | 2.35% |
| 2 | XNCR | Xencor | 2.32% |
| 3 | TRAX | First Tracks Biotherapeutics | 2.05% |
| 4 | SLS | SELLAS Life Sciences Group | 2.03% |
| 5 | REPL | Replimune Group | 1.84% |
| 6 | ABCL | AbCellera Biologics | 1.74% |
| 7 | AMLX | Amylyx Pharmaceuticals | 1.56% |
| 8 | VRDN | Viridian Therapeutics | 1.52% |
| 9 | SGP | SpyGlass Pharma | 1.41% |
| 10 | MBX | MBX Biosciences | 1.24% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 29, 2025 | $0.66 |
| Dec 20, 2024 | Dec 27, 2024 | $0.24 |
| Dec 20, 2023 | Dec 29, 2023 | $0.0823 |
| Dec 20, 2017 | Dec 27, 2017 | $0.30 |
| Dec 21, 2015 | Dec 29, 2015 | $0.15 |